Vazakidou, Paraskevi
Evangelista, Sara
Li, Tianyi
Lecante, Laetitia L.
Rosenberg, Kristine
Koekkoek, Jacco
Salumets, Andres
Velthut-Meikas, Agne
Damdimopoulou, Pauliina
Mazaud-Guittot, Séverine
Fowler, Paul A.
Leonards, Pim E.G.
van Duursen, Majorie B.M.
Funding for this research was provided by:
European research project FREIA (825100)
Swedish Research Council FORMAS (2020-01621 and 2018-02280)
Estonian Research Council (PSG608, PRG1076, PSG608)
Horizon 2020 innovation grant (EU952516)
Article History
Received: 22 December 2023
Accepted: 15 May 2024
First Online: 22 May 2024
Declarations
:
: Fetal material was obtained as a part of the Scottish Advanced Fetal Research (SAFeR) Study as ap-proved by NHS Grampian Research Ethics Committees (REC 15/NS/0123). Women who underwent C-section gave consent to participate in the research project investigating the effects of EDCs on ovaries at Karolinska University Hospital Huddinge in Stockholm, Sweden, in accordance with the Declaration of Helsinki. Women who received IVF treatment and from whose follicular fluid samples were collected, were informed regarding the study, and they signed an informed written consent form complying with the Declaration of Helsinki.
: Not applicable.
: The authors declare no competing interests.